참고문헌
- Simmons MA, Bruce IA, Penney S, Wraith E, Rothera MP. Otorhinolaryngological manifestations of the mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol 2005;69:589-95. https://doi.org/10.1016/j.ijporl.2005.01.017
- Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 2005;28:1011-7. https://doi.org/10.1007/s10545-005-0112-z
- Keilmann A, Nakarat T, Bruce IA, Molter D, Malm G; HOS Investigators. Hearing loss in patients with mucopolysaccharidosis II: data from HOS - The Hunter Outcome Survey. J Inherit Metab Dis 2012;35:343-53. https://doi.org/10.1007/s10545-011-9378-5
- Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008;167:267-77. https://doi.org/10.1007/s00431-007-0635-4
- Da Costa V, O'Grady G, Jackson L, Kaylie D, Raynor E. Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis. Arch Otolaryngol Head Neck Surg 2012;138:1071-6. https://doi.org/10.1001/jamaoto.2013.597
- Lin HY, Shih SC, Chuang CK, Lee KS, Chen MR, Lin HC, et al. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses. Mol Genet Metab 2014;111:533-8. https://doi.org/10.1016/j.ymgme.2014.02.003
- Saeed H, Nichani J, Melling C, Raine CH, Khan I, Martin JM, et al. Feasibility of cochlear implantation in Mucopolysaccharidosis. Int J Pediatr Otorhinolaryngol 2013;77:1255-8. https://doi.org/10.1016/j.ijporl.2013.05.003
- Taibah K. The transmeatal approach: a new technique in cochlear and middle ear implants. Cochlear Implants Int 2009;10:218-28. https://doi.org/10.1179/cim.2009.10.4.218
- Kronenberg J, Migirov L, Baumgartner WD. The suprameatal approach in cochlear implant surgery: our experience with 80 patients. ORL J Otorhinolaryngol Relat Spec 2002;64:403-5. https://doi.org/10.1159/000067576
- Mitchell J, Berger KI, Borgo A, Braunlin EA, Burton BK, Ghotme KA, et al. Unique medical issues in adult patients with mucopolysaccharidoses. Eur J Intern Med 2016;34:2-10. https://doi.org/10.1016/j.ejim.2016.05.017
- Jones SA, Almassy Z, Beck M, Burt K, Clarke JT, Giugliani R, et al. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 2009;32:534-43. https://doi.org/10.1007/s10545-009-1119-7
- Friedmann DR, Amoils M, Germiller JA, Lustig LR, Glastonbury CM, Pramanik BK, et al. Venous malformations of the temporal bone are a common feature in CHARGE syndrome. Laryngoscope 2012;122:895-900. https://doi.org/10.1002/lary.23205
- Ganaha A, Tono T, Kaname T, Yanagi K, Higa T, Kondo S, et al. Suprameatal cochlear implantation in a CHARGE patient with a novel CHD7 variant and KALLMANN syndrome phenotype: a case report. Otol Neurotol 2017;38:990-5. https://doi.org/10.1097/mao.0000000000001481
- Wang RY, Braunlin EA, Rudser KD, Dengel DR, Metzig AM, Covault KK, et al. Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness. Mol Genet Metab 2014;111:128-32. https://doi.org/10.1016/j.ymgme.2013.11.001
- Tanyildizi Y, Gokce S, Marini F, Mayer AK, Kirschner S, Hennermann JB, et al. Vessel shape alterations of the vertebrobasilar arteries in Mucopolysaccharidosis type IVa (Morquio A) patients. Eur J Radiol 2017;93:128-33. https://doi.org/10.1016/j.ejrad.2017.05.026